Finance

Lists
Why is AEON down 10,97%?
Dive Deeper
AEON:NYSEAMERICAN
Aeon Biopharma Inc
0,28 USD
-10,97%
(-0,034) 1D
0,29 USD
+4,20% (+0,012)
After hours
Closed: 9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AEON...
Open
0,31 USD
High
0,32 USD
Low
0,28 USD
Mkt. cap
13,77 млн
Avg. vol.
13,16 млн
Volume
1,63 млн
52-wk high
1,45 USD
52-wk low
0,18 USD
EPS
-3,58 USD
Beta
0,69
Shares outstanding
49,88 млн
No. of employees
8
Open
0,31 USD
High
0,32 USD
Low
0,28 USD
Mkt. cap
13,77 млн
Avg. vol.
13,16 млн
Volume
1,63 млн
52-wk high
1,45 USD
52-wk low
0,18 USD
EPS
-3,58 USD
Beta
0,69
Shares outstanding
49,88 млн
No. of employees
8
News stories
From web sources and news partners
Profile
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology. Wikipedia
About Aeon Biopharma Inc
CEOMurthy Simhambhatla
Employees8
Founded2013
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
597,00 миң
1,61 млн
2,03 млн
2,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,33 млн
3,49 млн
3,90 млн
2,99 млн
Operating expense
2,93 млн
5,10 млн
5,94 млн
5,93 млн
Total operating expenses
2,93 млн
5,10 млн
5,94 млн
5,93 млн
Operating income
-2,93 млн
-5,10 млн
-5,94 млн
-5,93 млн
Other non operating income
-168,00 миң
-14,08 млн
2,94 млн
4,98 млн
EBT including unusual items
-4,54 млн
-37,14 млн
-11,79 млн
-1,16 млн
EBT excluding unusual items
-3,10 млн
-19,18 млн
-2,99 млн
-952,00 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,54 млн
-37,14 млн
-11,79 млн
-1,16 млн
Net profit margin
-
-
-
-
Earnings per share
-0,39
-3,72
-0,25
-0,02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,91 млн
-5,08 млн
-5,92 млн
-5,91 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору